Sell the Market, Buy These 5 Stocks

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

On Monday, the VIX Index broke 40 -- a very rare occurrence. The VIX is a short-term indicator of stock market volatility, but I'd suggest that at extreme values, it becomes a good long-term indicator of stock market valuation. While Monday's milestone implies that the market remains expensive at current prices, there are also clear opportunities to buy the shares of first-rate businesses on the cheap.

Extraordinary events, unusual markets
The VIX is "Wall Street's fear index." It tracks the market's expectation of how volatile stocks will be in the near term. The CBOE exchange calculates VIX index values based on the prices investors are willing to pay for options that provide downside protection for the S&P 500.

Since its inception in 1990, there have been only five periods during which the VIX has traded above 40. In each case, the initial spike was precipitated by an extraordinary event -- even a couple of Black Swans -- occurring in an unusual market context. The following table documents these dates, along with the S&P 500's annualized return from each date through yesterday:


Precipitating Event

Market Context

S&P 500 Incl. Dividends, Annualized Return Through Wednesday

Aug. 8, 2011 U.S. downgraded to AA Sovereign debt crisis --
May 6, 2010 Flash crash Sovereign debt crisis 1.5%
Sept. 18, 2008 Lehman Brothers bankruptcy Credit crisis (0.3%)
July 22, 2002 WorldCom bankruptcy Post Tech bubble bear market 5.6%
Sept. 17, 2001 9/11 attacks Post tech bubble bear market 2.7%
Aug. 31, 1998 Russia defaults on its debt Asian financial crisis 3%

Source: Yahoo! Finance, Standard & Poor's indexes.

Only the returns associated with the three earliest dates correspond to periods long enough to be meaningful. The returns achieved aren't disastrous, but neither are they enough to compensate investors for owning stocks -- they're well below stocks' long-term historical return.

The market isn't cheap enough to buy
That suggests that when the VIX breaks 40, the broad market may decline on the day, but it isn't cheap enough to buy. Our sample is very small, but there is economic logic behind the phenomenon. The Shiller P/E, which uses average 10-year real earnings instead of single-year earnings estimates, confirms that stocks were expensive on each of those days:

Time Frame

S&P 500, Shiller P/E Multiple

Long-term historical average 16.4
Present: Aug. 10 19.3
May 6, 2010 20.7
Sept. 18, 2008 19.1
July 22, 2002 24.3
Sept. 17, 2001 24.6
Aug. 31, 1998 30.7

Source: Robert Shiller's website.

Those results fit the notion that you shouldn't buy during the initial surge in volatility, because it signals that a legitimate correction has yet to occur. By legitimate correction, I'm referring to a market that returns to (and usually overshoots) its fair value.

The market isn't cheap
In sum, I don't believe the broad market is cheap enough to buy ... yet. Investors should refrain from putting money into index funds like the SPDR S&P 500 Index ETF (NYSE: SPY  ) , unless they do so as part of an automatic monthly program. If the S&P 500 were to drop a further 10%-15%, it would reach levels at which investors can expect to earn returns roughly equal to the historical average (6.5%, after inflation). Note that this holds true only over periods adequate for equity investing -- 10 years, at a minimum. A 6.5% real return may sound like peanuts, but it's nothing to scoff at.

Prefer individual stocks to the broad market
The good news is that individual stocks aren't uniformly expensive. In fact, the following names sport very attractive valuations:

  • The consumer-staples sector is a smart, defensive choice in a very difficult economy. Two of the leading companies in that sector, Colgate-Palmolive (NYSE: CL  ) and Procter & Gamble (NYSE: PG  ) , are attractively priced relative to their earnings power.
  • The health-care sector will also hold up well if the economy deteriorates further. Johnson & Johnson (NYSE: JNJ  ) and GlaxoSmithKline (NYSE: GSK  ) are world-class franchises, but at less than 12 and 11 times forward earnings, respectively, they're priced as if they were mediocre businesses. Johnson & Johnson pays a dividend yield of 3.8%; at GlaxoSmithKline, it's 5.3%!
  • If you're willing to take a bit more risk, Wells Fargo (NYSE: WFC  ) is the highest-quality national megabank in the country, and you can buy its shares below book value. At these prices, you're paying a small premium over Berkshire Hathaway's cost basis on its position at the end of June. Berkshire is Wells Fargo's largest shareholder.

As you take advantage of this opportunity to look at specific stocks, keep in mind that there is no need to use up all your powder with a single shot. The market may yet offer up even better bargains.

Add all of these companies to My Watchlist.

Motley Fool Stock Advisor co-advisors Tom and David Gardner invite you to "Watch This Before the Market Crashes."

Fool contributor Alex Dumortier holds no position in any company mentioned. Click here to see his holdings and a short bio. You can follow him on Twitter. The Motley Fool owns shares of Johnson & Johnson and GlaxoSmithKline. The Fool owns shares of and has created a ratio put spread position on Wells Fargo. Motley Fool newsletter services have recommended buying shares of Procter & Gamble, Johnson & Johnson, and GlaxoSmithKline. Motley Fool newsletter services have recommended creating a diagonal call position in Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (8) | Recommend This Article (14)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 11, 2011, at 5:51 PM, TimothyVR wrote:

    I'll replace Wells Fargo with KO or MCD and leave the banks alone. I want to sleep at night.

  • Report this Comment On August 11, 2011, at 6:09 PM, xetn wrote:

    TimothyVR: I believe that is sound advise you can "bank" on.

  • Report this Comment On August 11, 2011, at 8:47 PM, JohnGoldsbury wrote:

    I'm not sure I understand the statement that "The CBOE exchange calculates VIX index values based on the prices investors are willing to pay for options that provide downside protection for the S&P 500." The VIX is based on prices for puts and calls. Certainly one might buy a put for downside protection. However, one could purchase a put or call for speculation, and one could sell a put or call for enhanced yield. Why is "fear" and "downside" protection so often assumed as the motive for option transactions? Seems to me it's just one of many.

  • Report this Comment On August 11, 2011, at 9:33 PM, TMFAleph1 wrote:

    "Why is "fear" and "downside" protection so often assumed as the motive for option transactions?"

    It is the motive in the situations I'm referring to. VIX doesn't spike based on purchases of out-of-the money calls. That's skew.

    You're right that it's more complicated than the description I give, but it's very difficult to give a full explanation of the VIX without taking readers down some rabbit holes.

    Alex Dumortier

  • Report this Comment On August 11, 2011, at 9:40 PM, PuddinHead42 wrote:

    It is easy to look at a P/E ratio or the Shiller P/E in a vacuum, but that is wrong to do. P/E must be taken in the context of alternate investments, traditionally bond yields. Right now short term yields are near zero and long term yields are extremely low, so I disagree that the market is not a value right now. Which is not to say your picks are wrong.

  • Report this Comment On August 11, 2011, at 9:53 PM, ElCid16 wrote:


    The author is likely speaking to history rather than speaking to other current investments. There are going to be periods when neither bonds nor stocks are a good investment. Just because bonds don't look good, surely you wouldn't automatically jump into stocks because they're a little better.

  • Report this Comment On August 11, 2011, at 10:05 PM, TMFAleph1 wrote:


    You've hit the nail on the head:

    "Just because bonds don't look good, surely you wouldn't automatically jump into stocks because they're a little better."

    Unfortunately, that's exactly what people are doing/ recommending. I hear it every day in market commentary -- it's absurd!

    Alex Dumortier

  • Report this Comment On August 12, 2011, at 2:19 PM, xtall wrote:

    Well, InvestorXrays, its just a comment. Nothing factual, nothing surprising, nothing worthwhile. Move on.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1537987, ~/Articles/ArticleHandler.aspx, 10/27/2016 9:03:33 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,169.68 -29.65 -0.16%
S&P 500 2,133.04 -6.39 -0.30%
NASD 5,215.97 -34.29 -0.65%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/27/2016 4:01 PM
CL $70.57 Down -0.69 -0.97%
Colgate-Palmolive CAPS Rating: ****
GSK $40.42 Up +0.08 +0.20%
GlaxoSmithKline CAPS Rating: ***
JNJ $115.70 Up +1.14 +1.00%
Johnson and Johnso… CAPS Rating: ****
PG $86.58 Down -0.82 -0.94%
Procter and Gamble CAPS Rating: ****
SPY $213.17 Down -0.57 -0.27%
S and P Depository… CAPS Rating: No stars
WFC $46.41 Up +0.26 +0.56%
Wells Fargo CAPS Rating: ****